DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
Cancers · 14.11.2023 · 15 (22) · 5411
DOI: 10.3390/cancers15225411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 14.11.2023. Verfasst von Florian Reinhardt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Heinrich Heine University of Duesseldorf, 40225 Duesseldorf, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Saxonian Parliament, German Cancer Aid.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Circulating tumor cells (CTCs) serve as crucial metastatic precursor cells, but their study in animal models has been hindered by their low numbers. To address this challenge, we present DanioCTC, an innovative xenograft workflow that overcomes the scarcity of patient-derived CTCs in animal models. By combining diagnostic leukapheresis (DLA), the Parsortix microfluidic system, flow cytometry, and the CellCelector setup, DanioCTC effectively enriches and isolates CTCs from metastatic breast cancer (MBC) patients for injection into zebrafish embryos. Validation experiments confirmed that MDA-MB-231 cells, transplanted following the standard protocol, localized frequently in the head and blood-forming regions of the zebrafish host. Notably, when MDA-MB-231 cells spiked (i.e., supplemented) into DLA aliquots were processed using DanioCTC, the cell dissemination patterns remained consistent. Successful xenografting of CTCs from a MBC patient revealed their primary localization in the head and trunk regions of zebrafish embryos. DanioCTC represents a major step forward in the endeavors to study the dissemination of individual and rare patient-derived CTCs, thereby enhancing our understanding of metastatic breast cancer biology and facilitating the development of targeted interventions in MBC. Summary statement: DanioCTC is a novel workflow to inject patient-derived CTCs into zebrafish, enabling studies of the capacity of these rare tumor cells to induce metastases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Heinrich Heine University of Duesseldorf, 40225 Duesseldorf, Germany.
- Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Duesseldorf), 53127 Bonn, Germany.
- Center for Regenerative Therapies TU Dresden (CRTD), Center for Molecular and Cellular Bioengineering (CMCB), TU Dresden, 01307 Dresden, Germany.
- Center for Healthy Aging, Faculty of Medicine Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
- Anatomical Institute, Neuroanatomy, Medical Faculty, University of Bonn, 53115 Bonn, Germany.
- ALS Automated Lab Solutions GmbH, 07745 Jena, Germany.
ORCID-Profile: Franziska Knopf, Hans Neubauer
Förderung
- Deutsche Forschungsgemeinschaft
- Saxonian Parliament
- German Cancer Aid
- German Research Foundation (DFG) Transregio 67
- DFG SPP 2084 μBone
- German Cancer Foundation (DKH) Priority Program ‘Translational Oncology’
Zitieren
APA
Reinhardt, F., Coen, L., Rivandi, M., Franken, A., Setyono, E. S. A., Lindenberg, T., Eberhardt, J., Fehm, T., Niederacher, D., Knopf, F., & Neubauer, H. (2023). DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts. Cancers, 15(22), 5411. https://doi.org/10.3390/cancers15225411
Vancouver
Reinhardt F, Coen L, Rivandi M, Franken A, Setyono ESA, Lindenberg T, et al. DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts. Cancers. 2023;15(22):5411. doi:10.3390/cancers15225411
BibTeX
@article{Reinhardt2023,
author = {Reinhardt, Florian and Coen, Luisa and Rivandi, Mahdi and Franken, André and Setyono, Eunike Sawitning Ayu and Lindenberg, Tobias and Eberhardt, Jens and Fehm, Tanja and Niederacher, Dieter and Knopf, Franziska and Neubauer, Hans},
title = {DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts},
journal = {Cancers},
year = {2023},
volume = {15},
number = {22},
pages = {5411},
doi = {10.3390/cancers15225411}
}
EUVIMED